欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/4958/001
药品名称Linagliptin Intas 5mg film-coated tablets
活性成分
    • linagliptin 5.0 mg
剂型Film-coated tablet
上市许可持有人Intas Third Party Sales 2005, S.L. World Trade Center Moll Barcelona s/n Edifici Est, 6th Floor 08039 Barcelona Spain
参考成员国 - 产品名称Netherlands (NL)
Linagliptin Intas 5mg film-coated tablets
互认成员国 - 产品名称
    • Poland (PL)
      Linagliptin Intas
    • Spain (ES)
    • Italy (IT)
    • Greece (GR)
许可日期2021/02/10
最近更新日期2024/09/12
药物ATC编码
    • A10BH05 linagliptin
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase